COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,226 Articles (22,733 medRxiv, 8,493 bioRxiv)

Most recent first Previous |  Page 1032: Articles 10311-10320  | Next

Disease severity related to VOC dominance in unvaccinated SARS-CoV-2 positive adults without risk factors in Sweden
Wahlstrom, E., Bruce, D., Bennet-Bark, A. M., Walther, S., Hanberger, H., Stralin, K.
10.1101/2021.12.23.21268040 — Posted: 2021-12-27
Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine?
Ogura, W., Ohtsuka, K., Matsuura, S., Okuyama, T., Matsushima, S., Yamasaki, S., Miyagi, H., Sekiguchi, K., Ohnishi, H., Watanabe, T.
10.1101/2021.12.26.21268358 — Posted: 2021-12-27
Persisting Chemosensory Impairments in 366 Healthcare Workers Following COVID-19: An 11-Month Follow-up.
Bussiere, N., Mei, J., Levesque-Boissonneault, C., Blais, M., Carazo, S., Gros-Louis, F., Laforce, R., DeSerres, G., Dupre, N., Frasnelli, J.
10.1101/2021.12.20.21268066 — Posted: 2021-12-27
Humoral and cellular immune responses to SARS CoV-2 vaccination in Persons with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
Bock, H., Juretzek, T., Handreka, R., Ruhnau, J., Reuner, K., Peltroche, H., Dressel, A.
10.1101/2021.12.22.21268127 — Posted: 2021-12-27
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies
Sormani, M. P., Schiavetti, I., Inglese, M., Carmisciano, L., Laroni, A., Lapucci, C., Visconti, V., Serrati, C., Gandoglia, I., Tassinari, T., Perego, G., Brichetto, G., Gazzola, P., Mannironi, A., Stromillo, M. L., Cordioli, C., Landi, D., Clerico, M., Signoriello, E., Frau, J., Ferro, M. T., Di Sapio, A., Pasquali, L., Ulivelli, M., Marinelli, F., Manzino, M., Callari, G., Iodice, R., Liberatore, G., Caleri, F., Repice, A. M., Cordera, S., Battaglia, M. A., Salvetti, M., Franciotta, D., Uccelli, A.
10.1101/2021.12.23.21268177 — Posted: 2021-12-27
A simple and quick PCR based method for detection of Omicron variant of SARS-CoV-2
Puvar, A., Pandit, R., Chaudhari, A. M., Travadi, T., Shukla, N., Joshi, C., Joshi, M.
10.1101/2021.12.20.21268053 — Posted: 2021-12-27
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
Chechet, G. D., Kwaga, J. K., Yahaya, J., MacLeod, A., Adamson, W. E.
10.1101/2021.12.21.21268166 — Posted: 2021-12-27
Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Schell, T. L., Knutson, K. L., Saha, S., Wald, A., Phan, H. S., Almasry, M., Chun, K., Grimes, I., Lutz, M., Hayney, M. S., Farraye, F. A., Caldera, F.
10.1101/2021.12.22.21268217 — Posted: 2021-12-27
Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada
Ulloa, A. C., Buchan, S. A., Daneman, N., Brown, K. A.
10.1101/2021.12.24.21268382 — Posted: 2021-12-27 Discussion: Onsite
A model based on a high-resolution flux matrix explains the spread of diseases in a spatial network and the effect of mitigation strategies
Le Treut, G., Huber, G., Kamb, M., Kawagoe, K., McGeever, A., Miller, J., Pnini, R., Veytsman, B., Yllanes, D.
10.1101/2021.12.22.21268059 — Posted: 2021-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).